by North Woods | May 6, 2026 | Blog, Firm News
MADISON, Wis., May 6, 2026 — Venture Investors Health Fund, one of the Midwest’s longest-standing healthcare-focused venture firms, today announced its rebrand to Clarevia Ventures, a new name that reflects the firm’s sharpened focus on helping early-stage medtech and...
by North Woods | May 6, 2026 | Firm News
By Jim Adox, Managing Partner Today, we’re announcing that Venture Investors Health Fund is becoming Clarevia Ventures (pronounced Claire-VEE-ah). This is more than a new name. It is a clearer articulation of where we’ve been heading for years. Our firm started 40...
by North Woods | Apr 28, 2026 | Perspectives
By Joe Amaral, Chief Medical and Scientific Officer, Clarevia When I first heard the term “precision surgery,” I, of course, thought it must have been coined by a non-surgeon who has never been in the operating room. Every surgeon believes they are being...
by North Woods | Mar 24, 2026 | Blog, Perspectives
By Jenni Le, Principal, Clarevia A patient suspected of sleep apnea used to spend the night in a lab, hooked up to sensors, trying to sleep in an unfamiliar environment, often producing a poor representation of a typical night. Today, that same patient can sleep in...
by North Woods | Mar 4, 2026 | Blog, Perspectives
By Paul Weiss, PhD, Partner at Clarevia In breast cancer, there was a moment when outcomes changed dramatically, but only for certain patients. Herceptin, an antibody therapy, was developed to target an overexpression of the HER2 protein. If a patient was...
